SwePub
Sök i LIBRIS databas

  Extended search

AMNE:(MEDICIN OCH HÄLSOVETENSKAP Medicinsk bioteknologi)
 

Search: AMNE:(MEDICIN OCH HÄLSOVETENSKAP Medicinsk bioteknologi) > (1990-1999) > Dimerization of the...

Dimerization of the human MUC2 mucin in the endoplasmic reticulum is followed by a N-glycosylation-dependent transfer of the mono- and dimers to the Golgi apparatus.

Asker, Noomi, 1968 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicinsk och fysiologisk kemi,Institute of Medical Biochemistry
Axelsson, Magnus A. B. (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicinsk och fysiologisk kemi,Institute of Medical Biochemistry
Olofsson, Sven-Olof, 1947 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicinsk och fysiologisk kemi,Institute of Medical Biochemistry
show more...
Hansson, Gunnar C., 1951 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicinsk och fysiologisk kemi,Institute of Medical Biochemistry
show less...
 (creator_code:org_t)
1998
1998
English.
In: The Journal of biological chemistry. - 0021-9258. ; 273:30, s. 18857-63
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Pulse-chase experiments in the colon cell line LS 174T combined with subcellular fractionation by sucrose density gradient centrifugation showed that the initial dimerization of the MUC2 apomucin started directly after translocation of the apomucin into the rough endoplasmic reticulum as detected by calnexin reactivity. As the mono- and dimers were chased, O-glycosylated MUC2 mono- and dimers were precipitated using an O-glycosylation-insensitive antiserum against the N-terminal domain of the MUC2 mucin. These O-glycosylated species were precipitated from the fractions that comigrated with the galactosyltransferase activity during the subcellular fractionation, indicating that not only MUC2 dimers but also a significant amount of monomers are transferred into the Golgi apparatus. Inhibition of N-glycosylation with tunicamycin treatment slowed down the rate of dimerization and introduced further oligomerization of the MUC2 apomucin in the endoplasmic reticulum. Results of two-dimensional gel electrophoresis demonstrated that these oligomers (putative tri- and tetramers) were stabilized by disulfide bonds. The non-N-glycosylated species of the MUC2 mucin were retained in the endoplasmic reticulum because no O-glycosylated species were precipitated after inhibition by tunicamycin. This suggests that N-glycans of MUC2 are necessary for the correct folding and dimerization of the MUC2 mucin.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)

Keyword

Anti-Bacterial Agents
pharmacology
Biological Transport
Active
Dimerization
Endoplasmic Reticulum
drug effects
metabolism
Gastric Mucins
biosynthesis
Glycosylation
Golgi Apparatus
drug effects
metabolism
Humans
Mucin-2
Mucins
metabolism
Neoplasm Proteins
metabolism
Subcellular Fractions
metabolism
Tumor Cells
Cultured
Tumor Markers
Biological
Tunicamycin
pharmacology
Ultracentrifugation

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view